2, 4, 6, 8: Protecting two- and four-legged animals
from the six- and eight-legged arthropods
National Program 104 includes projects that work toward better solutions for protection of humans and food animals from damaging arthropods. Although the program concentrates its efforts on priority pests, it covers a wide variety of topics, especially in veterinary entomology.
To read more about NP 104 Accomplisments, please click on the link: FY 12 Annual Report
Twelve different ARS locations perform research for National Program 104. These laboratories include 14 main projects, 66 subordinate projects, and 3 specially funded projects. There are 80 scientists working full or part time on the program in the United States, Panama, and Greece.
To read more about NP 104 Accomplishments, please click on the link: FY 11 Annual Report
National Program 104 involves efforts in 11 units at 12 different locations performed by more than 80 scientists. The subjects of investigations concern improvements in integrated pest management for termites, ants, mosquitoes, biting midges, sand flies, biting and filth flies, screwworm flies, bed bugs, and ticks.
To read more about NP 104 Accomplishments, please click on the link: FY 10 Annual Report
National Program 104 involves efforts in 10 units at 8 different locations performed by more than 80 scientists. The subjects of investigations concern improvements in integrated pest management for termites, ants, mosquitoes, biting midges, sand flies, biting and filth flies, screwworm flies, bed bugs, and ticks.
To read more about NP 104 Accomplishments, please click on the link: FY 09 Annual Report
The goal of National Program 104 (NP 104) is to perform research that contributes to efficient and safe protection of humans and animals from damage caused by arthropods. To achieve this goal, research within NP 104 uses a framework of components in the idealized structure of applied entomology known as Integrated Pest Management (IPM).
To read more about NP 104 Accomplishments, please click on the link: FY 08 Annual Report
